Showing results (141-150 of 277) with videos related to

Sort By:
Pageof 28
Rheumatology (Oxford, England)|February 1, 2022
Pharmacological treatment in adult patients with CRPS-I: a systematic review and meta-analysis of randomized controlled trialsAngelo Fassio, Alessandro Mantovani, Davide Gatti, et al.
Calcified Tissue International|February 24, 2017
Denosumab for the Treatment of Mastocytosis-Related Osteoporosis: A Case SeriesGiovanni Orsolini, Irene Gavioli, Gaia Tripi, et al.
Therapeutic Advances in Musculoskeletal Disease|September 26, 2022
Comparable long-term retention rates and effects on bone mineral density of denosumab treatment in patients with osteoporosis with or without autoimmune inflammatory rheumatic diseases: real-life dataAngelo Fassio, Davide Gatti, Davide Bertelle, et al.
Optics Express|October 6, 2012
250-MHz synchronously pumped optical parametric oscillator at 2.25-2.6 μm and 4.1-4.9 μmNicola Coluccelli, Helge Fonnum, Magnus Haakestad, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|April 24, 2023
Bone Loss in Inflammatory Rheumatic Musculoskeletal Disease Patients Treated With Low-Dose Glucocorticoids and Prevention by Anti-Osteoporosis MedicationsGiovanni Adami, Angelo Fassio, Maurizio Rossini, et al.
European Journal of Endocrinology|July 2, 2010
GH in combination with bisphosphonate treatment in osteogenesis imperfectaFranco Antoniazzi, Elena Monti, Giacomo Venturi, et al.
The Journal of Chemical Physics|February 23, 2015
Comb-locked cavity ring-down spectrometerDavide Gatti, Tommaso Sala, Riccardo Gotti, et al.
Bone Reports|June 17, 2026
The natural history of osteogenesis imperfecta: a systematic reviewDavide Gatti, Samantha Prince, Ogün Sazova, et al.
Clinical and Experimental Rheumatology|July 7, 2012
Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritisMassimo Varenna, Maria Manara, Francesco P Cantatore, et al.
Journal of the American Academy of Dermatology|May 17, 2011
Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatibThomas M Rünger, Silvano Adami, Claude-Laurent Benhamou, et al.
Pageof 28